Evolution of the Average Target: Medical Properties Trust, Inc.

Evolution of the Target Price: Medical Properties Trust, Inc.

Changes in Analyst Recommendations: Medical Properties Trust, Inc.

f252d854a7dc4baf6d.MQYZxwrm9xXUSkaoba3yVqoEAAFIuZ19cIGvNncDEK0.Y1JMkWOImliXGgXLWOGDIOtOcU4n7KwEIu78BBF1J9wJbWz1SZeib-Fncg~69942aaa7eb4707e4488f4d43e40995a
06-18 RBC Cuts Price Target on Medical Properties Trust to $4.50 From $5, Keeps Sector Perform, Speculative Risk MT
03-02 RBC Raises Price Target on Medical Properties Trust to $5 From $4.50, Keeps Sector Perform, Speculative Risk MT
30/06/25 RBC Lowers Price Target on Medical Properties Trust to $4.50 From $5, Keeps Sector Perform, Speculative Risk MT
12/03/25 BNP Paribas Exane Upgrades Medical Properties Trust to Outperform From Neutral, Raises Price Target to $9 From $5 MT
10/03/25 RBC Raises Price Target on Medical Properties Trust to $5 From $4, Keeps Sector Perform, Speculative Risk MT
13/09/24 Colliers Upgrades Medical Properties Trust to Buy From Neutral, Price Target is $6.50 MT
12/09/24 Truist Securities Raises Price Target on Medical Properties Trust to $6 From $5, Maintains Hold Rating MT
02/07/24 BNP Paribas Exane Downgrades Medical Properties Trust to Neutral From Outperform, Adjusts Price Target to $4 From $6 MT
30/05/24 Truist Adjusts Price Target on Medical Properties Trust to $5 From $4.50, Maintains Hold Rating MT
14/05/24 RBC Downgrades Medical Properties Trust to Sector Perform From Outperform, Price Target is $5 Amid Tenant-Related Concerns MT
14/05/24 RBC Downgrades Medical Properties Trust to Sector Perform From Outperform, Price Target is $5 MT
17/04/24 Deutsche Bank Upgrades Medical Properties Trust to Hold From Sell, Adjusts PT to $5 From $2 MT
08/04/24 Truist Securities Raises Price Target on Medical Properties Trust to $4.50 From $4, Maintains Hold Rating MT
01/03/24 BNP Paribas Exane Upgrades Medical Properties Trust to Outperform From Neutral, Price Target is $6 MT
20/02/24 RBC Cuts Price Target on Medical Properties Trust to $5 From $8 on Steward-Related Rent Disruption, Keeps Outperform, Speculative Risk MT
05/01/24 KeyBanc Downgrades Medical Properties Trust to Sector Weight From Overweight, Removes $15 Price Target Amid Uncertainty, Risks to Tenant Health MT
03/01/24 Mizuho Securities Adjusts Medical Properties Trust's Price Target to $7 From $9, Keeps Neutral Rating MT
28/11/23 RBC Cuts Price Target on Medical Properties Trust to $8 From $10, Keeps Outperform Rating MT
10/11/23 Stifel Downgrades Medical Properties Trust to Hold From Buy, Adjusts Price Target to $4.50 From $12 MT
16/10/23 Wells Fargo Downgrades Medical Properties Trust to Underweight From Equalweight, Cuts Price Target to $4 From $7 MT
31/08/23 Mizuho Downgrades Medical Properties Trust to Neutral From Buy, Adjusts Price Target to $9 From $18 MT
22/08/23 Barclays Adjusts Price Target on Medical Properties Trust to $10 From $12, Maintains Overweight Rating MT
21/08/23 JPMorgan Downgrades Medical Properties Trust to Underweight From Neutral, Adjusts Price Target to $7 From $9 MT
21/08/23 Analyst recommendations: Alphabet, AstraZeneca, FMC Corp, Target, Wise... Zonebourse
14/08/23 RBC Adds Speculative Risk Qualifier to Outperform Rating on Medical Properties Trust, Cuts PT to $10 From $12 After 'Disappointing' Q2 Results MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+20.3%
+2.78%
+0.57%
-0.38%
-0.21%
+5.01%
+6.65%
+16.53%
+3.01%
+13.04%
Average +6.73%
Weighted average by Cap. +2.99%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
4.750USD
Average target price
5.714USD
Spread / Average Target
+20.30%
High Price Target
8.000USD
Spread / Highest target
+68.42%
Low Price Target
4.500USD
Spread / Lowest Target
-5.26%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

RBC Capital Markets
BNP Paribas Exane
Colliers Securities
Truist Securities
Deutsche Bank Securities
KeyBanc Capital Markets
Mizuho Securities
Stifel Nicolaus
Wells Fargo Securities
Barclays
JPMorgan Chase
BofA Securities
Raymond James
Credit Suisse
Berenberg Bank
Jefferies & Co.
Wolfe Research
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
4.750USD
Average target price
5.714USD
Spread / Average Target
+20.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MPT Stock
  4. Consensus Medical Properties Trust, Inc.